Latest Diagnostic tests Stories
SAN DIEGO, July 27, 2011 /PRNewswire/ -- bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today study results published in the next issue of the Journal of Molecular Diagnostics related to the clinical validity and the clinical utility of CancerTYPE IDÂ®, its 92-gene molecular classification test to aid in the determination of the origin of a tumor.
Part of agency's efforts to promote development of personalized medicines and diagnostics SILVER SPRING, Md., July 12, 2011 /PRNewswire-USNewswire/ --The U.S.
When a person living in a malarial area gets a fever, health workers need to know the cause to make absolutely sure they give the right treatment.
NEW YORK and QUEBEC CITY, June 29, 2011 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focusing on oncology, and DiagnoCure, Inc.
IRVINE, Calif., June 17, 2011 /PRNewswire/ -- ResearchDx, LLC of Irvine, California today announced a strategic partnership with CompanDX of Nottingham UK.
SAN DIEGO, June 7, 2011 /PRNewswire/ -- bioTheranostics, Inc., a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company's CancerTYPE IDÂ®, and Breast Cancer Index(SM).
UNION CITY, Calif., June 7, 2011 /PRNewswire/ -- Abaxis, Inc.
QUEBEC CITY, June 6, 2011 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a life sciences company commercializing high value cancer diagnostic tests and delivering laboratory services, today reported financial and operation results for the second quarter of fiscal 2011.
BEIJING, June 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.